[A novel orthopaedic biodegradable polymer and its biocompatibility]

Area of Science:

• Biomaterials Science
• Polymer Chemistry
• Orthopedic Surgery

Background:

• Biodegradable polymers are crucial for orthopedic implants, offering a temporary solution that avoids removal surgery.
• Polycaprolactone (PCL) and polylactic acid (PLA) are well-established biodegradable polymers with distinct properties.
• Developing novel copolymers with tunable degradation profiles remains a key challenge in orthopedic biomaterials.

Purpose of the Study:

• To synthesize and characterize a novel copolymer of polycaprolactone (PCL) and polylactic acid (PLA).
• To evaluate the biocompatibility and degradation properties of the synthesized PCL-PLA copolymer for orthopedic applications.
• To investigate the potential of this copolymer as an ideal orthopedic biodegradable implant material.

Main Methods:

• Copolymer synthesis using Yttrium(III) trifluoroacetate (Y(CF3COO)3) and Aluminum triisobutoxide (Al(I-Bu)3) as catalysts.
• Biocompatibility assessment through biochemical assays, immunocytochemistry, and cytotoxicity testing.
• Evaluation of degradation characteristics by controlling copolymer molecular weight and polymer ratios.

Main Results:

• Successful synthesis of a PCL-PLA copolymer with controlled properties.
• Demonstrated biocompatibility through various in vitro tests, indicating minimal cellular toxicity.
• Established a correlation between molecular weight, polymer ratio, and the degradation period of the copolymer.

Conclusions:

• The synthesized PCL-PLA copolymer exhibits excellent biocompatibility and tunable degradation, making it a promising candidate for orthopedic biodegradable implants.
• Adjusting the molecular weight and the ratio of PCL to PLA in the copolymer allows for precise control over its degradation timeline.
• This novel biodegradable polymer represents a significant advancement in the field of orthopedic biomaterials, potentially improving patient outcomes.